John Sapienza

433 total citations
4 papers, 154 citations indexed

About

John Sapienza is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, John Sapienza has authored 4 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 1 paper in Pharmacology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in John Sapienza's work include PI3K/AKT/mTOR signaling in cancer (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). John Sapienza is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). John Sapienza collaborates with scholars based in Switzerland and United States. John Sapienza's co-authors include Rama Krishna Narla, Joseph R. Piccotti, Massimo Ammirante, Antonia Lopez‐Girona, Joshua D. Hansen, Mark A. Nagy, Michael Pourdehnad, Yang Tang, Laurie A. LeBrun and Dehua Huang and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

John Sapienza

4 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Sapienza Switzerland 3 116 44 43 25 18 4 154
Gillian M. Lamont United Kingdom 8 156 1.3× 58 1.3× 75 1.7× 9 0.4× 29 1.6× 15 243
Jen-Shin Song Taiwan 10 111 1.0× 24 0.5× 86 2.0× 64 2.6× 6 0.3× 14 254
Kenneth J. Stauffer United States 7 77 0.7× 41 0.9× 59 1.4× 51 2.0× 13 0.7× 7 164
Anup Aggarwal United States 6 130 1.1× 28 0.6× 23 0.5× 16 0.6× 7 0.4× 9 160
Yann‐Vaï Le Bihan United Kingdom 10 244 2.1× 22 0.5× 44 1.0× 13 0.5× 10 0.6× 17 281
Floriana De Bellis Italy 8 263 2.3× 52 1.2× 30 0.7× 18 0.7× 15 0.8× 8 309
Ryan Stansfield United States 8 281 2.4× 53 1.2× 60 1.4× 6 0.2× 15 0.8× 11 355
Jacqueline L. Norris‐Drouin United States 11 362 3.1× 85 1.9× 40 0.9× 36 1.4× 16 0.9× 20 392
Pascal Savy United Kingdom 8 141 1.2× 42 1.0× 70 1.6× 8 0.3× 7 0.4× 11 211
Jitendra K. Mishra India 7 113 1.0× 35 0.8× 103 2.4× 6 0.2× 7 0.4× 20 238

Countries citing papers authored by John Sapienza

Since Specialization
Citations

This map shows the geographic impact of John Sapienza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sapienza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sapienza more than expected).

Fields of papers citing papers by John Sapienza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Sapienza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sapienza. The network helps show where John Sapienza may publish in the future.

Co-authorship network of co-authors of John Sapienza

This figure shows the co-authorship network connecting the top 25 collaborators of John Sapienza. A scholar is included among the top collaborators of John Sapienza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Sapienza. John Sapienza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Hansen, Joshua D., Matthew Correa, Mark A. Nagy, et al.. (2021). CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 64(4). 1835–1843. 100 indexed citations
2.
Mortensen, Deborah S., John Sapienza, Brandon Whitefield, et al.. (2013). Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase. Bioorganic & Medicinal Chemistry Letters. 23(6). 1588–1591. 20 indexed citations
3.
4.
McKie, Jeffrey A., Shripad S. Bhagwat, Helen Brady, et al.. (2004). Lead identification of a potent benzopyranone selective estrogen receptor modulator. Bioorganic & Medicinal Chemistry Letters. 14(13). 3407–3410. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian M. Lamont Breakdown of academic impact, for papers by Jen-Shin Song Breakdown of academic impact, for papers by Kenneth J. Stauffer Breakdown of academic impact, for papers by Anup Aggarwal Breakdown of academic impact, for papers by Yann‐Vaï Le Bihan Breakdown of academic impact, for papers by Floriana De Bellis Breakdown of academic impact, for papers by Ryan Stansfield Breakdown of academic impact, for papers by Jacqueline L. Norris‐Drouin Breakdown of academic impact, for papers by Pascal Savy Breakdown of academic impact, for papers by Jitendra K. Mishra
Rankless by CCL
2026